| Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma TO Nielsen, FD Hsu, K Jensen, M Cheang, G Karaca, Z Hu, ... Clinical cancer research 10 (16), 5367-5374, 2004 | 3697 | 2004 |
| ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ... New England Journal of Medicine 363 (16), 1532-1543, 2010 | 1974 | 2010 |
| Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells A Facciabene, X Peng, IS Hagemann, K Balint, A Barchetti, LP Wang, ... Nature 475 (7355), 226-230, 2011 | 1432 | 2011 |
| Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non … KA Gelmon, M Tischkowitz, H Mackay, K Swenerton, A Robidoux, ... The lancet oncology 12 (9), 852-861, 2011 | 1366 | 2011 |
| Ovarian carcinoma subtypes are different diseases: implications for biomarker studies M Köbel, SE Kalloger, N Boyd, S McKinney, E Mehl, C Palmer, S Leung, ... PLoS medicine 5 (12), e232, 2008 | 989 | 2008 |
| Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary SP Shah, M Köbel, J Senz, RD Morin, BA Clarke, KC Wiegand, G Leung, ... New England Journal of Medicine 360 (26), 2719-2729, 2009 | 880 | 2009 |
| A clinically applicable molecular-based classification for endometrial cancers A Talhouk, MK McConechy, S Leung, HH Li-Chang, JS Kwon, N Melnyk, ... British journal of cancer 113 (2), 299-310, 2015 | 853 | 2015 |
| Confirmation of ProMisE: a simple, genomics‐based clinical classifier for endometrial cancer A Talhouk, MK McConechy, S Leung, W Yang, A Lum, J Senz, N Boyd, ... Cancer 123 (5), 802-813, 2017 | 813 | 2017 |
| Cancer-associated mutations in endometriosis without cancer MS Anglesio, N Papadopoulos, A Ayhan, TM Nazeran, M Noë, ... New England Journal of Medicine 376 (19), 1835-1848, 2017 | 625 | 2017 |
| Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series S Kommoss, MK McConechy, F Kommoss, S Leung, A Bunz, J Magrill, ... Annals of Oncology 29 (5), 1180-1188, 2018 | 620 | 2018 |
| A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells RB West, BP Rubin, MA Miller, S Subramanian, G Kaygusuz, ... Proceedings of the National Academy of Sciences 103 (3), 690-695, 2006 | 567 | 2006 |
| EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer L Hughes-Davies, D Huntsman, M Ruas, F Fuks, J Bye, SF Chin, J Milner, ... Cell 115 (5), 523-535, 2003 | 538 | 2003 |
| Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers A Heravi-Moussavi, MS Anglesio, SWG Cheng, J Senz, W Yang, ... New England Journal of Medicine 366 (3), 234-242, 2012 | 531 | 2012 |
| Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling A Bashashati, G Ha, A Tone, J Ding, LM Prentice, A Roth, J Rosner, ... The Journal of pathology 231 (1), 21-34, 2013 | 502 | 2013 |
| Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ... The lancet oncology 14 (9), 853-862, 2013 | 482 | 2013 |
| Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors K Milne, M Köbel, SE Kalloger, RO Barnes, D Gao, CB Gilks, PH Watson, ... PloS one 4 (7), e6412, 2009 | 480 | 2009 |
| Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers S Chia, B Norris, C Speers, M Cheang, B Gilks, AM Gown, D Huntsman, ... Journal of Clinical Oncology 26 (35), 5697-5704, 2008 | 446 | 2008 |
| Differences in tumor type in low-stage versus high-stage ovarian carcinomas M Köbel, SE Kalloger, DG Huntsman, JL Santos, KD Swenerton, ... International Journal of Gynecological Pathology 29 (3), 203-211, 2010 | 426 | 2010 |
| Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma CB Gilks, E Oliva, RA Soslow The American journal of surgical pathology 37 (6), 874-881, 2013 | 425 | 2013 |
| TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data G Ha, A Roth, J Khattra, J Ho, D Yap, LM Prentice, N Melnyk, ... Genome research 24 (11), 1881-1893, 2014 | 418 | 2014 |
